Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability

Andrew C Newby1

  • 1Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK. A.Newby@bris.ac.uk

Insights

Matrix metalloproteinases (MMPs) degrade arterial proteins, potentially causing plaque rupture. Targeting MMP overproduction in macrophages offers a promising therapeutic strategy for cardiovascular diseases.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Immunology

Background:

  • Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins, including collagen.
  • MMP overproduction by macrophages is implicated in atherosclerotic plaque instability and myocardial infarction.
  • Macrophage activation state influences MMP expression profiles.

Purpose of the Study:

  • To investigate the regulation of MMPs by different macrophage populations.
  • To explore the role of prostaglandin-dependent pathways in MMP induction.
  • To identify potential therapeutic targets for controlling MMP activity in atherosclerosis.

Main Methods:

  • Analysis of MMP expression in freshly-recruited versus differentiated macrophages.
  • Investigation of prostaglandin-mediated signaling pathways.
  • Characterization of MMP and inhibitor spectra in distinct macrophage phenotypes.

Main Results:

  • Freshly-recruited macrophages upregulate a broad spectrum of MMPs via a prostaglandin-dependent pathway.
  • Differentiated macrophages exhibit selective MMP upregulation through distinct pathways.
  • Evidence suggests differential MMP and inhibitor expression based on macrophage phenotype.

Conclusions:

  • Macrophage MMP production is differentially regulated based on activation state and phenotype.
  • Targeting MMP overproduction presents a potential therapeutic avenue for preventing atherosclerotic plaque rupture and myocardial infarction.